Glucotrack Inc. announced it has regained full compliance with Nasdaq's listing requirements following the restoration of its minimum equity threshold.
The biotechnology company, which develops continuous glucose monitoring systems, had previously faced a compliance issue related to its stockholders' equity. Nasdaq rules mandate listed companies maintain a minimum level of equity to remain on the exchange, a requirement Glucotrack now meets.
The firm did not disclose the specific equity figure or the duration of the compliance deficiency. No additional financial or operational details were provided in the announcement.
Nasdaq compliance is critical for publicly traded companies as it ensures market integrity and investor confidence. Companies that fail to meet listing standards typically receive a compliance period to rectify deficiencies before facing delisting.
Glucotrack's shares trade under the ticker GLUC on the Nasdaq Capital Market. The company did not respond to requests for comment beyond its regulatory filing.
